Publication/Creation Date

August 5 2019

Creators/Contributors

Arizona State University (creator)
Lucille M. Tournas (creator)
Walter G. Johnson (creator)
Elon Musk (contributor)
Neuralink Corp. (contributor)
Food And Drug Administration (FDA) (contributor)

Description

With Neuralink and other BCI companies pressing forward, the time has come for both regulators to take the technology seriously and industry to place patient protection at the center of innovation. Rather than uncontrollably accelerate innovation, the BCI industry will need to make a good faith effort to work with device regulators to protect patients. In turn, the FDA may need to pursue more flexible programs for speedy, yet safe innovation. Failure to compromise could instead lead to patient harm or exploitation under the guise of progress. 

Augments

Regulating, Controlling, Protecting, Preventing, Treating

Technology Keywords

Brain-Computer Interface (BCI), Brain-Machine Interface (BMI), Artificial Intelligence (AI), Electrodes, Smartphone Applications, Medical Device, Digital Telepathy, Brain Implanted AI

Keywords

Ethics, Neuroethics, Safety, Security, Privacy, Medical, Healthcare, Law, Policy, Patients, Futurism

Marketing Keywords

Neuralink Corp., Kernel, Facebook

Source

https://slate.com/technology/2019/08/elon-musk-neuralink-facebook-brain-computer-interface-fda.html